🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Cerebellar tDCS in Children With Autism Spectrum Disorder

RecruitingNAAges 4 Years - 17 YearsAllUniversity of Texas Southwestern Medical Center
NCT04446442 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this research study is to investigate whether tDCS to the cerebellum (specifically, the right crus I/II area of the cerebellum) of children and young adults with autism spectrum disorders (ASD) is safe and to examine its effects on some of the symptoms of ASD, such as repetitive behaviors and hyperactivity.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * 4-17 years old * Diagnosed with ASD and ADOS-2 * IQ Score no less than 70 (1.5 Standard Deviations below the mean) * Language Level (Speech consists of, at minimum, flexible, spontaneous, simple, sentences) Exclusion Criteria: * Brain implants, metal implants, pacemakers, or biomedical devices * Diagnosis of epilepsy * Hearing or visual impairments * History of brain injury * Known brain abnormalities not associated with ASD
💊

What it tests

  • tDCS
📍

Where

2 sites
Children's Medical Center
Dallas, United States
University of Texas Southwestern
Dallas, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy